---
title: "Multi-ancestry GWAS Reveals Shared and Distinct Genetic Architecture in Mild vs Moderate-to-Severe"
id: "medrxiv-1-multi-ancestry-genome-wide-association-analyses-identify-shared-and-specific"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-multi-ancestry-genome-wide-association-analyses-identify-shared-and-specific"
content_type: "clinical_feed_article"
specialty: "Pulmonology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1?rss=1"
published_at: "2026-09-22T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Multi-ancestry GWAS Reveals Shared and Distinct Genetic Architecture in Mild vs Moderate-to-Severe
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-multi-ancestry-genome-wide-association-analyses-identify-shared-and-specific
- **Specialty:** [Pulmonology](https://medichelpline.com/clinical-feed/pulmonology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1?rss=1)
- **Published At:** 2026-09-22T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This preprint reports separate multi-ancestry genome-wide association studies (GWAS) comparing **mild asthma** (N = 14,372) and **moderate-to-severe asthma** (N = 7,096) against non-asthma controls (N = 28,816) in adult participants from the NIH All of Us Research Program (version 8). - Analyses combined European, African, and Latino/admixed ancestry-specific GWAS using fixed-effect meta-analysis to identify susceptibility loci and shared versus phenotype-specific signals. - Shared susceptibility loci included IL1RL1, IKZF3, and regions around GTF3AP1-IL33, GTF3AP1-RANBP6, LINC02757-EMSY, and HLA-DRB1-HLA-DQA1; lung eQTLs implicated IL18R1, IL18RAP, HLA genes, IL33, LRRC32, GRB7, MIEN1 and GSDMB. - Mild asthma showed broader **HLA class II** signals and associations at SMAD3 and GSDMB; pathway enrichment suggested adaptive immune mechanisms (antigen presentation, T-helper cell differentiation, TGF-β regulation). - Moderate-to-severe asthma exhibited distinct associations at WDR36 and PTCH1; lung eQTLs implicated TSLP, CAMK4, and FANCC, with pathway enrichment for IL-13, IL-6, IL-10 production, myeloid leukocyte differentiation and oxidative stress responses—consistent with innate inflammation and steroid resistance mechanisms. - The **IL33** locus demonstrated a severity-gradient effect, with stronger association in moderate-to-severe asthma. - The authors conclude that mild and moderate-to-severe asthma share loci but have distinct genetic architectures, supporting existing biologic targets and suggesting novel therapeutic candidates. - The study used publicly available All of Us data; ethical approvals and participant consent are reported; funders include NIAID (R21AI193971) and NIEHS (Z01 ES102005, Z01 ES025041). - As a medRxiv preprint, the work has not been peer reviewed and should not guide clinical practice.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=wVOZ3qEMKhezuPDCxI8pZGLfNRo_JU42VFfLINQncjQ-1790111254.7994554-1.2.1.1-S2pcx_hEz5dO6_.amYdsjOSxghawHqnb575jO5T5WhLIvKjJm_ylnfo1tQBusxNR) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Multi-Ancestry Genome-wide Association Analyses Identify Shared and Specific Genetic Architecture in Mild and Moderate-to-Severe Asthma [ View ORCID Profile](http://orcid.org/0000-0002-8227-6830)Angelico Mendy, Yadu Gautam, Bradley H. Rosen, Joseph Castlen, Michael B. Fessler, Darryl C. Zeldin, Peter S. Thorne, Tesfaye B. Mersha doi: https://doi.org/10.64898/2026.09.20.26363488 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Angelico Mendy 1 Louisiana State University Health Sciences Center; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Angelico%2BMendy%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mendy%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAngelico%2BMendy%2B) * [ORCID record for Angelico Mendy](http://orcid.org/0000-0002-8227-6830 "Open in new tab") * For correspondence: amendy@lsuhsc.edu Yadu Gautam 2 Indiana University School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yadu%2BGautam%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Gautam%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYadu%2BGautam%2B) Bradley H. Rosen 2 Indiana University School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Bradley%2BH.%2BRosen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rosen%20BH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABradley%2BH.%2BRosen%2B) Joseph Castlen 2 Indiana University School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Joseph%2BCastlen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Castlen%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJoseph%2BCastlen%2B) Michael B. Fessler 3 National Institute for Environmental Health Sciences; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BB.%2BFessler%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fessler%20MB&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BB.%2BFessler%2B) Darryl C. Zeldin 3 National Institute for Environmental Health Sciences; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Darryl%2BC.%2BZeldin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Zeldin%20DC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADarryl%2BC.%2BZeldin%2B) Peter S. Thorne 4 University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Peter%2BS.%2BThorne%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Thorne%20PS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APeter%2BS.%2BThorne%2B) Tesfaye B. Mersha 2 Indiana University School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tesfaye%2BB.%2BMersha%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mersha%20TB&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATesfaye%2BB.%2BMersha%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1305303/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1305303/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1305303/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1305303/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1305303/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1305303/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Moderate-to-severe asthma affects 15-30% of asthma patients, but accounts for over 50% of healthcare costs and disproportionate morbidity. However, the genetic mechanisms underlying moderate-to-severe versus mild asthma remain poorly understood. Methods: We performed separate pooled multi-ancestry GWAS of mild (N = 14,372) and moderate-to-severe asthma (N = 7,096) versus non-asthma controls (N = 28,816) among adult participants in the NIH All of Us Research Program (version 8). European, African, and Latino/admixed ancestry-specific GWAS were combined using fixed-effect meta-analysis. Lung expression quantitative trait loci (eQTL) and pathway analyses were performed to identify candidate genes and biological pathways across asthma phenotypes. Results: Mild and moderate-to-severe asthma shared susceptibility loci at IL1RL1, IKZF3, and the GTF3AP1-IL33, GTF3AP1-RANBP6, LINC02757-EMSY and HLA-DRB1-HLA-DQA1 regions. Shared lung eQTLs implicated IL18R1, IL18RAP, HLA genes, IL33, LRRC32, GRB7, MIEN1 and GSDMB. In contrast, the phenotypes exhibited distinct genetic architectures. Mild asthma was characterized by broader HLA class II signals and associations at SMAD3 and GSDMB, with enrichment of antigen presentation, T-helper cell differentiation, and TGF-β regulation, consistent with adaptive immune mechanisms. Moderate-to-severe asthma was characterized by WDR36 and PTCH1, with lung eQTLs implicating TSLP, CAMK4, and FANCC. Pathway analysis identified enrichment of IL-13, IL-6, and IL-10 production, myeloid leukocyte differentiation, and oxidative stress responses, consistent with innate inflammation and pathways implicated in steroid resistance. The IL33 signals showed a severity-gradient effect, with stronger associations in moderate-to-severe asthma. Conclusion: Mild and moderate-to-severe asthma exhibit shared and distinct genetic architectures that support existing biologic targets and suggest novel therapeutic candidates. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: NIH All of Us Research Program I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability This present study used publicly available data available through the workbench of the NIH All of Us Research Program. ## Funder Information Declared National Institute of Allergy and Infectious Diseases, https://ror.org/043z4tv69, R21AI193971 National Institute of Environmental Health Sciences, https://ror.org/00j4k1h63, Z01 ES102005, Z01 ES025041 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC 4.0 International license](http://creativecommons.org/licenses/by-nc/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.16.26363278v1 "Menstrual Health in South India: Knowledge, Stigma, and Barriers to Participation")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.16.26363244v1 "Contextual factors shaping the delivery of routine immunisation services in the Mumbunda Health Zone, Democratic Republic of the Congo: a multiple case study of head nurses' experiences") Posted September 22, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/22/2026.09.20.26363488.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.09.20.26363488v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/22/2026.09.20.26363488.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Multi-Ancestry Genome-wide Association Analyses Identify Shared and Specific Genetic Architecture in Mild and Moderate-to-Severe Asthma Angelico Mendy, Yadu Gautam, Bradley H. Rosen, Joseph Castlen, Michael B. Fessler, Darryl C. Zeldin, Peter S. Thorne, Tesfaye B. Mersha medRxiv 2026.09.20.26363488; doi: https://doi.org/10.64898/2026.09.20.26363488 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.20.26363488v1%26text%3DMulti-Ancestry%2520Genome-wide%2520Association%2520Analyses%2520Identify%2520Shared%2520and%2520Specific%2520Genetic%2520Architecture%2520in%2520Mild%2520and%2520Moderate-to-Severe%2520Asthma "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.20.26363488v1%26t%3DMulti-Ancestry%2520Genome-wide%2520Association%2520Analyses%2520Identify%2520Shared%2520and%2520Specific%2520Genetic%2520Architecture%2520in%2520Mild%2520and%2520Moderate-to-Severe%2520Asthma "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.20.26363488v1%26title%3DMulti-Ancestry%2520Genome-wide%2520Association%2520Analyses%2520Identify%2520Shared%2520and%2520Specific%2520Genetic%2520Architecture%2520in%2520Mild%2520and%2520Moderate-to-Severe%2520Asthma%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.20.26363488v1%26title%3DMulti-Ancestry%2520Genome-wide%2520Association%2520Analyses%2520Identify%2520Shared%2520and%2520Specific%2520Genetic%2520Architecture%2520in%2520Mild%2520and%2520Moderate-to-Severe%2520Asthma "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.20.26363488) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.20.26363488v1&count=horizontal&via=&text=Multi-Ancestry%20Genome-wide%20Association%20Analyses%20Identify%20Shared%20and%20Specific%20Genetic%20Architecture%20in%20Mild%20and%20Moderate-to-Severe%20Asthma&counturl=www.medrxiv.org/content/10.64898/2026.09.20.26363488v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (619) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (904) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (335) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4836) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (479) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (419) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (651) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1634) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15982) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (33) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1206) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7071) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (734) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1067) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5072) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1438) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1777) * [Hematology](https://www.medrxiv.org/collection/hematology) (587) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1347) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16313) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1177) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (673) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (155) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (727) * [Neurology](https://www.medrxiv.org/collection/neurology) (7312) * [Nursing](https://www.medrxiv.org/collection/nursing) (370) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1087) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1245) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1007) * [Oncology](https://www.medrxiv.org/collection/oncology) (3622) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1058) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (398) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (458) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (476) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (140) * [Pathology](https://www.medrxiv.org/collection/pathology) (709) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1805) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (739) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (769) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5925) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9779) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2438) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1456) * [R
## Related Clinical Research

- [Extended Treatment Duration and Recurrence in Cavitary Drug-Susceptible Pulmonary Tuberculosis](https://medichelpline.com/clinical-feed/plos-one-11-extended-treatment-duration-and-recurrence-in-successfully-treated-drug.md)
- [Triglyceride-Glucose (TyG) Index and Mortality in Non-Diabetic Fibrotic Lung Disease on Antifibrot](https://medichelpline.com/clinical-feed/plos-one-1-association-between-triglyceride-glucose-index-and-all-cause-mortality-in-non.md)
- [Nasal transcriptomics identify five asthma endotypes including T2‑low profiles in Puerto Rican and](https://medichelpline.com/clinical-feed/medrxiv-18-nasal-transcriptomics-characterize-t-helper-t-2-low-asthma-endotypes-in-a-study.md)
- [AI-designed lung drug rentosertib shows shifts in proteomic aging clocks in phase 2a trial](https://medichelpline.com/clinical-feed/medical-news-today-0-ai-designed-lung-disease-drug-lowers-biological-age-markers-in-early-trial.md)
- [Input Complexity Trade-offs for Transformer Models in Longitudinal EHR Asthma Prediction](https://medichelpline.com/clinical-feed/medrxiv-20-rethinking-input-complexity-in-transformer-based-clinical-prediction.md)

## Navigation
- [← Back to Pulmonology Feed](https://medichelpline.com/clinical-feed/pulmonology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.